SYK Stock Recent News

Stryker Corporation is a global leader in medical devices, with strong growth prospects driven by an aging population and technological advancements. SYK has a robust track record of double-digit earnings growth and high single-digit organic revenue growth, outperforming peers. Stryker's innovative products, like the Mako robot, and strategic acquisitions bolster its market position and future growth potential.

Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial results show robust performance, with net sales up 8.5%, adjusted EPS up 10.6%, and a healthy balance sheet with reduced long-term debt. Stryker's growth prospects are supported by organic growth, acquisitions, and expanding margins, alongside a modest but growing dividend, making it an attractive stock for growth investors.

Stryker SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boost its competitiveness and add capabilities.

Styker's flagship, Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the quarter ended September 30, 2024.

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.

Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions.